They are often at high risk due to a genetic predisposition toward the disease, of which mutations in breast cancer type 1 susceptibility protein (BRCA1) and breast cancer type 2 susceptibility protein (BRCA2) tumor suppressive genes are the best characterized 3. This evidence concerns the gene BRCA1 and neoplasm.